BioNTech

News

CureVac claims advantage in BioNTech patent dispute

A court in Germany has suspended a trial discussing litigation brought against BioNTech and Pfizer by CureVac alleging patent infringement in connection with their mRNA-ba

News

FDA clears new Pfizer, Moderna COVID jabs as cases tick up

The FDA has authorised updated versions of Pfizer/BioNTech and Moderna's mRNA-based COVID-19 vaccines targeting the XBB.1.5 subvariant, in time for the start of a new autu

News

Moderna, Pfizer say COVID jabs work against BA.2.86

Moderna and Pfizer have both said that updated versions of their COVID-19 vaccines work against the highly mutated BA.2.86 variant, also known as Pirola, which is being cl

News

BioNTech and Takeda add new ADCs to their pipelines

A pair of licensing deals today for BioNTech and Takeda provide further examples that antibody-drug conjugates (ADCs) are cementing their place as in the biopharma armamen

Oncology

Could cancer be the next mRNA breakthrough?

mRNA vaccines achieved their first success against COVID-19, but could a cancer target be next?

News

US eyes link between Pfizer bivalent COVID jab and stroke

Regulatory authorities in the US are investigating a possible link between the new Pfizer/BioNTech bivalent COVID-19 booster vaccine and strokes in people aged 65 or over, but still recomme

CureVac claims advantage in BioNTech patent dispute

FDA clears new Pfizer, Moderna COVID jabs as cases tick up

Moderna, Pfizer say COVID jabs work against BA.2.86

BioNTech and Takeda add new ADCs to their pipelines

Could cancer be the next mRNA breakthrough?

US eyes link between Pfizer bivalent COVID jab and stroke

Allogeneic cell therapy isn’t dead, with Brian Culley

How to meet your physicians where they are online

BioNTech

Editor's Picks